Interestingly, TRAF6 is overexpressed in HSC from myelodysplastic syndrome (MDS) patients as compared to healthy individuals (42, 43), and chronic innate immune signaling via TRAF6 has been implicated in hematopoietic defects associated with MDS (31, 43–47). Here, TRAF6 is linked to myelodysplastic syndrome.